# Feasibility of Transepicardial Atrial Injection

> **NCT05634213** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Ottawa Heart Institute Research Corporation**

## Conditions studied

- Cardiac Surgery

## Interventions

- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT05634213
- **Lead sponsor:** Ottawa Heart Institute Research Corporation
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-03-01
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Logistical issues
- **Last updated:** 2023-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05634213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05634213, "Feasibility of Transepicardial Atrial Injection". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05634213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*